Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|April 11, 2025
Discovery of novel JAK3 inhibitors for the treatment of atopic dermatitisWeijie Ren, Lifang Cen, Xinyue Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 24, 2016
Further understanding of an uncommon disease of combined small cell lung cancer: clinical features and prognostic factors of 114 casesYu Men, Zhouguang Hui, Jun Liang, et al.
Scientific Reports|October 12, 2016
Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and stagingJing Xu, Yanhua Chen, Ruiping Zhang, et al.
ACS Sensors|February 9, 2024
pH-Tuned Enantioselectivity Reversal in a Defective Chiral Metal Organic FrameworkXiaohui Niu, Mei Yuan, Rui Zhao, et al.
Thoracic Cancer|August 15, 2015
Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapyZhouguang Hui, Honghai Dai, Jun Liang, et al.
Biomed Research International|March 11, 2017
MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment OutcomesWei Jiang, Wenjue Zhang, Lihong Wu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 12, 2021
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trialXu Yang, Yirui Zhai, Nan Bi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
ATM polymorphisms are associated with risk of radiation-induced pneumonitisLi Zhang, Ming Yang, Nan Bi, et al.
Cell Death & Disease|September 19, 2018
MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biologyGuogui Sun, Xiao Ding, Nan Bi, et al.
Radiation Oncology (London, England)|June 22, 2020
Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trialZhixue Fu, Xu Yang, Wenqing Wang, et al.
Pageof 17